In July 2021, MorphoSys acquired Constellation Pharmaceuticals. This transformational acquisition bolstered MorphoSys’ position as a leader in hematology and oncology and marked the beginning of an important next chapter in the company's history. MorphoSys’ mission is more life for people with cancer. As a global commercial-stage biopharmaceutical company, MorphoSys uses groundbreaking science and technologies to discover, develop, and deliver innovative cancer medicines to patients. MorphoSys is headquartered in Planegg, Germany, and has its U.S. operations anchored in Boston, Massachusetts. Read more about the acquisition here: https://www.morphosys.com/media-investors/media-center/morphosys-to-complete-transformational-acquisition-of-constellation Learn more about MorphoSys: www.MorphoSys.com
View Top Employees from Constellation Pharmaceuticals, A MorphoSys Company| Website | http://www.morphosys.com/ |
| Ticker | CNST |
| Revenue | $27 million |
| Funding | $708 million |
| Employees | 80 (80 on RocketReach) |
| Founded | 2008 |
| Address | 470 Atlantic Ave, Boston, Massachusetts 02110, US |
| Phone | (617) 714-0555 |
| Fax | (617) 577-0472 |
| Technologies |
JavaScript,
HTML,
PHP
+48 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Drug Manufacturing & Research, Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare, Genetics, Health Care, Medical, Pharmaceutical |
| Web Rank | 3 Million |
| Keywords | Constellation Pharmaceuticals, Patrick Trojer, Constellation Therapeutics, Pharmaceuticals Cambridge Ma, Constellation Pharam |
| Competitors | Chlorion Pharma, G1 Therapeutics, Inc., Metacrine, Inc., OYAGEN INC., Xenon Pharmaceuticals Inc. |
| SIC | SIC Code 80 Companies, SIC Code 283 Companies, SIC Code 2834 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 5413 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54138 Companies |
Looking for a particular Constellation Pharmaceuticals, A MorphoSys Company employee's phone or email?
Constellation Pharmaceuticals, A MorphoSys Company Questions
The Constellation Pharmaceuticals, A MorphoSys Company annual revenue was $27 million in 2024.
Patrick Trojer is the Chief Scientific Officer of Constellation Pharmaceuticals, A MorphoSys Company.
80 people are employed at Constellation Pharmaceuticals, A MorphoSys Company.
Constellation Pharmaceuticals, A MorphoSys Company is based in Boston, Massachusetts.
The NAICS codes for Constellation Pharmaceuticals, A MorphoSys Company are [5413, 541, 54, 54138].
The SIC codes for Constellation Pharmaceuticals, A MorphoSys Company are [80, 283, 2834, 28].
Top Constellation Pharmaceuticals, A MorphoSys Company Employees
-
ViewPatrick Trojer
Chief Scientific Officer at Constellation Pharmaceuticals, A MorphoSys Company
Reading, Massachusetts, United States15+ -
View
Rick Fritz
Director, Supply Chain at Constellation Pharmaceuticals, A MorphoSys Company
Palm Springs, CA, US31
Related Companies
